SCHEMBL4555744

SCHEMBL4555744

CCCCCCNC(CCC(N)=O)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 9/20 0.61
ITGB3 P05106 1/20 0.46
ITGA2B P08514 1/20 0.46
MEN1 O00255 1/20 0.42
FAAH O00519 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
SOAT1 P35610 1/20 0.42
KMT2A Q03164 1/20 0.42
GPR84 Q9NQS5 3/20 0.41
FFAR1 O14842 1/20 0.41
PLA2G2A P14555 2/20 0.40
PLA2G5 P39877 2/20 0.40
SLC6A5 Q9Y345 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
MMP12 P39900 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL750125 1.00 NOD1 (0.61) NOD1ITGB3ITGA2BMEN1FAAH
SCHEMBL8749121 1.00 NOD1 (0.61) NOD1ITGB3ITGA2BMEN1FAAH
SCHEMBL750126 1.00 NOD1 (0.61) NOD1ITGB3ITGA2BMEN1FAAH
SCHEMBL6698113 1.00 NOD1 (0.61) NOD1ITGB3ITGA2BMEN1FAAH
SCHEMBL7350355 1.00 NOD1 (0.61) NOD1ITGB3ITGA2BMEN1FAAH
SCHEMBL8749149 1.00 NOD1 (0.61) NOD1ITGB3ITGA2BMEN1FAAH
SCHEMBL794473 1.00 NOD1 (0.61) NOD1ITGB3ITGA2BMEN1FAAH
SCHEMBL8749146 1.00 NOD1 (0.61) NOD1ITGB3ITGA2BMEN1FAAH
SCHEMBL8749129 1.00 NOD1 (0.61) NOD1ITGB3ITGA2BMEN1FAAH
SCHEMBL2251086 1.00 NOD1 (0.61) NOD1ITGB3ITGA2BMEN1FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2018568-A1 HDL CHOLESTEROL SENSOR USING SELECTIVE SURFACTANT Oxford Biosensors Limited (GB) 2009-01-28 EP claimed
WO-2007132222-A1 HDL CHOLESTEROL SENSOR USING SELECTIVE SURFACTANT OXFORD BIOSENSORS LTD (GB) 2007-11-22 WO claimed
CN-110352243-B Method for concentrating and recovering target nucleic acid using antibody 积水医疗株式会社 2024-05-28 CN disclosed
US-20240147994-A1 ENHANCED YEASTICIDAL EFFICACY OF LACTIC ACID BASED ANTIMICROBIAL HANDWASH ECOLAB USA INC. 2024-05-09 US disclosed
WO-2024086642-A1 ENHANCED YEASTICIDAL EFFICACY OF LACTIC ACID BASED ANTIMICROBIAL HANDWASH ECOLAB USA INC. (US) 2024-04-25 WO disclosed
CN-116601488-A Method and consumer product for detecting metabolites 金伯利-克拉克环球有限公司 2023-08-15 CN disclosed
EP-3284809-B1 CLEANING COMPOSITION PROCTER & GAMBLE (US) 2019-09-25 EP disclosed
US-20180051232-A1 CLEANING COMPOSITION THE PROCTER & GAMBLE COMPANY 2018-02-22 US disclosed
WO-2018035191-A1 CLEANING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2018-02-22 WO disclosed
EP-3284809-A1 CLEANING COMPOSITION The Procter & Gamble Company (US) 2018-02-21 EP disclosed
US-20130115315-A1 COSMETIC ANTIDANDRUFF COMPOSITION BASED ON ELLAGIC ACID OR A DERIVATIVE THEREOF AND A SECOND, DIFFERENT ACTIVE COMPOUNT IN A SPECIFIC WEIGHT RATIO L'OREAL (FI) 2013-05-09 US disclosed
US-5744644-A INCLUDING SOLVENT OF WATER, ALCOHOL, OR WATER/ALCOHOL MIXTURE; INTERMEDIATES FOR POLYHYDROXYALKYLCARBOXAMIDES HOECHST AKTIENGESELLSCHAFT (DE) 1998-04-28 US disclosed
EP-0571198-B1 Cosmetic composition containing hair-growth promoter UNILEVER PLC (GB) 1997-03-19 EP disclosed
US-5559092-A HAIR GROWTH, GLUTAMINE DIPEPTIDE CHESEBROUGH-POND'S USA CO. DIVISION OF CONOPCO, INC. (US) 1996-09-24 US disclosed
EP-0550636-B1 LIQUID DETERGENT COMPOSITIONS PROCTER & GAMBLE (US) 1995-09-13 EP disclosed
EP-0571198-A1 Cosmetic composition containing hair-growth promoter UNILEVER PLC (GB) 1993-11-24 EP disclosed
EP-0550636-A1 LIQUID DETERGENT COMPOSITIONS. PROCTER & GAMBLE (US) 1993-07-14 EP disclosed
WO-1992006171-A1 LIQUID DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1992-04-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130115315-A1 COSMETIC ANTIDANDRUFF COMPOSITION BASED ON ELLAGIC ACID OR A DERIVATIVE THEREOF AND A SECOND, DIFFERENT ACTIVE COMPOUNT IN A SPECIFIC WEIGHT RATIO SCLY, ETF1, SELENOI NOD1 1545/4885ITGB3 4630/4885ITGA2B 4636/4885
US-20240147994-A1 ENHANCED YEASTICIDAL EFFICACY OF LACTIC ACID BASED ANTIMICROBIAL HANDWASH WASHC4, DERA, ADH1C NOD1 3582/4885ITGB3 3650/4885ITGA2B 3552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.